Stock listing

NASDAQ:ALXN Alexion Pharmaceuticals Inc Stock

Follow Alexion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ALXN

$182.50 USD

Close on Jul 21, 2021 · No longer trades

May 23, 2011 to last close +285.6% · monthly closes, May 23, 2011 – Jul 21, 2021
Lowest – highest close
$44.61 – $207.84 USDSince May 23, 2011 · lowest Jun 17, 2011 · highest Jul 23, 2015

Delisted NASDAQ:ALXN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ALXN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Alexion Pharmaceuticals Inc on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Oct 29, 2020
Decks
6 decks · latest Feb 11, 2021

Events

CallWhenStatus
Alexion Pharmaceuticals (0QZM) Q3 2020 Earnings CallThu, Oct 29, 2020 · 8:00 AM ETReplay
Alexion Pharmaceuticals (0QZM) Q2 2020 Earnings CallThu, Jul 30, 2020 · 8:00 AM ETReplay
Alexion Pharmaceuticals (0QZM) Q1 2020 Earnings CallWed, May 06, 2020 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
FY2020 Earnings PresentationEarnings19 slidesFeb 11, 2021
39th Annual J.P. Morgan Healthcare Conference (January 2021)Conference35 slidesJan 12, 2021
Merger or Acquisition (December 2020)Merger or acquisition26 slidesDec 14, 2020
38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference35 slidesJan 13, 2020
Merger or Acquisition (October 2019)Merger or acquisition19 slidesOct 21, 2019
Merger or Acquisition (October 2019)Merger or acquisition21 slidesOct 16, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · Jun 22, 2015 – May 14, 2020 · Past
Julian Baker
Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past)
Director · Jun 22, 2015 – May 14, 2020 · Past
David J Anderson
Other companies: Corteva, Inc. (EVP, Chief Financial Officer · Apr 12, 2021 – Apr 12, 2024 · Past); Criteo SA (Interim CFO · May 18, 2020 – May 18, 2020 · Past); Nielsen Holdings PLC (CFO/COO · Sep 10, 2018 – Dec 5, 2019 · Past); Fifth Street Asset Management Inc (Director · Oct 29, 2014 – Jun 4, 2015 · Past); B/E Aerospace Inc (Director · Jun 10, 2014 – Apr 13, 2017 · Past); Cardinal Health, Inc. (Director · Apr 25, 2014 – Jan 16, 2018 · Past); American Electric Power Company, Inc. (Director · Apr 26, 2011 – Mar 31, 2022 · Past); Honeywell International Inc. (Sr. VP & CFO · Jan 6, 2006 – Apr 4, 2014 · Past)
EVP, Chief Financial Officer · Dec 12, 2016 – Dec 12, 2016 · Past
François Nader
Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Acceleron Pharma Inc (Director · Dec 11, 2014 – Nov 19, 2021 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past)
Director · Nov 15, 2017 – Jul 21, 2021 · Past
Judith A. Reinsdorf
Other companies: Toll Brothers, Inc. (Member of the Governance Committee · Since at least Dec 13, 2023); Nurix Therapeutics, Inc. (Director · Since at least Oct 1, 2021); Enpro Inc. (Director · Since at least Sep 1, 2021); Cornerstone Building Brands Inc (Director · Aug 19, 2021 – Jul 25, 2022 · Past); Dun & Bradstreet Holdings Inc. (Director · Jun 12, 2013 – Feb 8, 2019 · Past); Johnson Controls International plc (Executive VP & General Counsel · Mar 12, 2007 – Oct 12, 2017 · Past)
Director · Feb 5, 2018 – Jul 21, 2021 · Past
Martin Mackay
Other companies: Kailera Therapeutics, Inc. (Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026); SpringWorks Therapeutics Inc (Director · Since at least Jul 29, 2024); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past)
EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past
R Douglas Norby
Other companies: Krystal Biotech, Inc. (Director · Sep 19, 2017 – May 31, 2018 · Past); Invensense Inc. (Director · Nov 15, 2011 – Sep 15, 2013 · Past); Magnachip Semiconductor Corporation (Director · Mar 10, 2011 – Mar 11, 2016 · Past); Ikanos Communications Inc (Director · Jan 5, 2011 – Oct 31, 2012 · Past); Intellon Corp (Director · Dec 12, 2007 – Dec 15, 2009 · Past); Tessera Technologies Inc (Officer · Jan 10, 2006 – Feb 23, 2006 · Past)
Director · Jan 9, 2006 – May 10, 2017 · Past
Brian Goff
Other companies: Intellia Therapeutics, Inc. (Independent Director · Since at least Jun 13, 2024); Agios Pharmaceuticals, Inc. (Chief Executive Officer · Since at least Aug 8, 2022); Baxalta Inc (EVP and President, Hematology · Jun 30, 2015 – Jun 3, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Mar 27, 2012 – Mar 27, 2012 · Past)
EVP & Chief Commercial Officer · Jun 1, 2017 – Jul 21, 2021 · Past
John Moriarty
Other companies: Kardigan, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 17, 2026); Avidity Biosciences, Inc (Chief Legal Officer · Since at least Aug 1, 2024); Olema Pharmaceuticals, Inc. (EVP, Ch. Legal Officer & Sec. · Sep 19, 2020 – Feb 1, 2023 · Past); Portola Pharmaceuticals Inc (EVP, General Counsel · Mar 12, 2018 – Jul 2, 2020 · Past)
EVP & General Counsel · Dec 10, 2012 – Feb 6, 2018 · Past
Vikas Sinha
Other companies: Scholar Rock Holding Corporation (Chief Financial Officer · Since at least Apr 27, 2025); Verona Pharma plc (Director · Since at least Jan 1, 2021); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Kalaris Therapeutics, Inc. (See Remarks, Director · Jul 29, 2020 – Feb 21, 2025 · Past)
EVP & CFO · Jul 12, 2013 – Aug 8, 2016 · Past
All 25 people
PersonSeat
Christopher J Coughlin
Other companies: Centene Corporation (Director · Since at least Jan 5, 2022); Prestige Consumer Healthcare Inc. (Director · Aug 3, 2021 – Aug 2, 2022 · Past); Karuna Therapeutics Inc (Director · Jun 16, 2021 – Mar 18, 2024 · Past)
Director · May 20, 2021 – Jul 21, 2021 · Past
Indrani Lall Franchini
Other companies: Avanos Medical, Inc. (Director · Since at least Jul 1, 2024); Alnylam Pharmaceuticals, Inc. (EVP, CLO & Secretary · Jan 31, 2022 – Feb 27, 2024 · Past)
EVP, Chief Compliance Officer · Feb 6, 2018 – Jul 21, 2021 · Past
Ludwig Hantson
Other companies: Ionis Pharmaceuticals, Inc. (Director · Since at least Jun 4, 2026); Hologic Inc (Director · Since at least Mar 11, 2021)
CEO, Director · Dec 16, 2020 – Jul 21, 2021 · Past
Edward Miller
Other companies: Kalaris Therapeutics, Inc. (General Counsel · Jul 29, 2020 – Feb 21, 2025 · Past)
SVP, Chief Compliance Officer · Sep 9, 2016 – Feb 27, 2017 · Past
Larry Mathis
Other companies: Healthcare Realty Trust Incorporated (Director · Dec 8, 2010 – Jul 9, 2019 · Past)
Director · May 12, 2010 – Feb 28, 2014 · Past
Ruedi E Waeger
Other companies: Talecris Biotherapeutics Holdings Corp (Director · Sep 30, 2009 – Jun 1, 2011 · Past)
Director · Jan 9, 2006 – May 3, 2010 · Past
Tanisha Carino
Other companies: Silk Road Medical Inc (Director · Jul 22, 2021 – Sep 17, 2024 · Past)
EVP & CCAO · Nov 4, 2019 – Jul 21, 2021 · Past
Thomas Dubin
Other companies: Intensity Therapeutics, Inc. (Board Member · Since at least May 14, 2024)
SVP & Chief Legal Officer · Jul 11, 2007 – Aug 23, 2012 · Past
Andreas RummeltDirector · Feb 23, 2010 – Jul 21, 2021 · Past
Christopher F MojcikSVP Clinical Development · Jan 9, 2006 – May 29, 2007 · Past
Clare CarmichaelEVP, Chief HR Officer · Aug 29, 2011 – Feb 27, 2017 · Past
Daniel BazarkoSVP, Controller, CAO · Feb 14, 2019 – Jul 21, 2021 · Past
Joseph A MadriDirector · Jan 9, 2006 – Mar 11, 2014 · Past
Leonard BellDirector · May 11, 2016 – Feb 28, 2017 · Past
William R KellerDirector · May 12, 2010 – Dec 4, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Alexion Pharmaceuticals Inc.